Worth reading
64In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
500000
unitsWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of the 9th Series of Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause)
Who receives how much50,000,000Shares
Number of potential shares represented by this issuance: 50,000,000 shares
EVO FUND: 500,000 units
The lower thin line represents the existing number of shares to which these shares will be added.
¥18 per stock acquisition right
Total issue value
¥9,000,000
Amount of funds to be raised
¥11,458,520,000 (¥9,000,000 from the issuance of these stock acquisition rights and ¥11,500,000,000 from the exercise of these stock acquisition rights, after deducting issuance expenses)
Estimated issuance expenses
¥50,480,000
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥230 per share. An adjustment clause applies based on 100% of the closing price or the average closing price. Minimum exercise price: ¥115.
Exercise period
From 31 March 2026 to 30 September 2027
Number of Stock Acquisition Rights
Total issued: 500,000 units. Remaining unexercised units: Not disclosed.
Payment date
30 March 2026
Basis for determining the amount to be paid
The initial exercise price is ¥230 per share. The exercise price will be adjusted based on 100% of the closing price on 13 March 2026 or 100% of the simple average closing price for the 2 consecutive trading days preceding the adjustment date. The minimum exercise price is ¥115.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of the 9th Series of Stock Acquisition Rights through third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Number of potential shares represented by this issuance: 50,000,000 shares |
| Issue price and disposal price | ¥18 per stock acquisition right |
| Total issue value | ¥9,000,000 |
| Amount of funds to be raised | ¥11,458,520,000 (¥9,000,000 from the issuance of these stock acquisition rights and ¥11,500,000,000 from the exercise of these stock acquisition rights, after deducting issuance expenses) |
| Estimated issuance expenses | ¥50,480,000 |
| Payment date | 30 March 2026 |
| Intended allottee | EVO FUND: 500,000 units |
| Basis for determining the amount to be paid | The initial exercise price is ¥230 per share. The exercise price will be adjusted based on 100% of the closing price on 13 March 2026 or 100% of the simple average closing price for the 2 consecutive trading days preceding the adjustment date. The minimum exercise price is ¥115. |
| Exercise price | Initial exercise price: ¥230 per share. An adjustment clause applies based on 100% of the closing price or the average closing price. Minimum exercise price: ¥115. |
| Exercise period | From 31 March 2026 to 30 September 2027 |
| Number of Stock Acquisition Rights | Total issued: 500,000 units. Remaining unexercised units: Not disclosed. |
Items this document does not state (16)
Specific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited enhancing corporate and shareholder value, rebuilding and strengthening its business platform, developing the platform for medium- to long-term growth, expanding its business and recovering performance, and strengthening its capital base.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.